440 related articles for article (PubMed ID: 9660364)
1. Perinatal HIV-1 transmission: interaction between zidovudine prophylaxis and mode of delivery in the French Perinatal Cohort.
Mandelbrot L; Le Chenadec J; Berrebi A; Bongain A; Bénifla JL; Delfraissy JF; Blanche S; Mayaux MJ
JAMA; 1998 Jul; 280(1):55-60. PubMed ID: 9660364
[TBL] [Abstract][Full Text] [Related]
2. Prevention of vertical HIV transmission: additive protective effect of elective Cesarean section and zidovudine prophylaxis. Swiss Neonatal HIV Study Group.
Kind C; Rudin C; Siegrist CA; Wyler CA; Biedermann K; Lauper U; Irion O; Schüpbach J; Nadal D
AIDS; 1998 Jan; 12(2):205-10. PubMed ID: 9468370
[TBL] [Abstract][Full Text] [Related]
3. The mode of delivery and the risk of vertical transmission of human immunodeficiency virus type 1--a meta-analysis of 15 prospective cohort studies.
; Andiman W; Bryson Y; de Martino M; Fowler M; Harris D; Hutto C; Korber B; Kovacs A; Landesman S; Lindsay M; Lapointe N; Mandelbrot L; Newell M-L; Peavy H; Read J; Rudin C; Semprini A; Simonds R; Tuomala R
N Engl J Med; 1999 Apr; 340(13):977-87. PubMed ID: 10099139
[TBL] [Abstract][Full Text] [Related]
4. [Vertical transmission of HIV infection: risk factors and prevention strategies].
Grignaffini A; Cavatorta E; Verrotti C; Soncini E; Pelicelli A; Fieni S; Magnani G; Benaglia G
Acta Biomed Ateneo Parmense; 2000; 71(5):167-78. PubMed ID: 11450119
[TBL] [Abstract][Full Text] [Related]
5. Determinants of mother-to-infant human immunodeficiency virus 1 transmission before and after the introduction of zidovudine prophylaxis.
Italian Register for Human Immunodeficiency Virus Infection in Children
Arch Pediatr Adolesc Med; 2002 Sep; 156(9):915-21. PubMed ID: 12197800
[TBL] [Abstract][Full Text] [Related]
6. A "bloodless cesarean section" and perinatal transmission of the human immunodeficiency virus.
Towers CV; Deveikis A; Asrat T; Major C; Nageotte MP
Am J Obstet Gynecol; 1998 Sep; 179(3 Pt 1):708-14. PubMed ID: 9757976
[TBL] [Abstract][Full Text] [Related]
7. Cesarean deliveries and maternal-infant HIV transmission: results from a prospective study in South Africa.
Kuhn L; Bobat R; Coutsoudis A; Moodley D; Coovadia HM; Tsai WY; Stein ZA
J Acquir Immune Defic Syndr Hum Retrovirol; 1996 Apr; 11(5):478-83. PubMed ID: 8605593
[TBL] [Abstract][Full Text] [Related]
8. Factors predictive of maternal-fetal transmission of HIV-1. Preliminary analysis of zidovudine given during pregnancy and/or delivery.
Boyer PJ; Dillon M; Navaie M; Deveikis A; Keller M; O'Rourke S; Bryson YJ
JAMA; 1994 Jun 22-29; 271(24):1925-30. PubMed ID: 7911164
[TBL] [Abstract][Full Text] [Related]
9. Cost-effectiveness of cesarean section delivery to prevent mother-to-child transmission of HIV-1.
Halpern MT; Read JS; Ganoczy DA; Harris DR
AIDS; 2000 Apr; 14(6):691-700. PubMed ID: 10807192
[TBL] [Abstract][Full Text] [Related]
10. Elective cesarean delivery plus short-course lamivudine and zidovudine for the prevention of mother-to-child transmission of human immunodeficiency virus type 1.
Panburana P; Sirinavin S; Phuapradit W; Vibhagool A; Chantratita W
Am J Obstet Gynecol; 2004 Mar; 190(3):803-8. PubMed ID: 15042018
[TBL] [Abstract][Full Text] [Related]
11. Identification of levels of maternal HIV-1 RNA associated with risk of perinatal transmission. Effect of maternal zidovudine treatment on viral load.
Dickover RE; Garratty EM; Herman SA; Sim MS; Plaeger S; Boyer PJ; Keller M; Deveikis A; Stiehm ER; Bryson YJ
JAMA; 1996 Feb; 275(8):599-605. PubMed ID: 8594240
[TBL] [Abstract][Full Text] [Related]
12. Acceptability and impact of zidovudine for prevention of mother-to-child human immunodeficiency virus-1 transmission in France.
Mayaux MJ; Teglas JP; Mandelbrot L; Berrebi A; Gallais H; Matheron S; Ciraru-Vigneron N; Parnet-Mathieu F; Bongain A; Rouzioux C; Delfraissy JF; Blanche S
J Pediatr; 1997 Dec; 131(6):857-62. PubMed ID: 9427890
[TBL] [Abstract][Full Text] [Related]
13. Is intrapartum intravenous zidovudine for prevention of mother-to-child HIV-1 transmission still useful in the combination antiretroviral therapy era?
Briand N; Warszawski J; Mandelbrot L; Dollfus C; Pannier E; Cravello L; Nguyen R; Matheron I; Winer N; Tubiana R; Rouzioux C; Faye A; Blanche S;
Clin Infect Dis; 2013 Sep; 57(6):903-14. PubMed ID: 23728147
[TBL] [Abstract][Full Text] [Related]
14. Risk factors for perinatal transmission of human immunodeficiency virus type 1 in women treated with zidovudine. Pediatric AIDS Clinical Trials Group Study 185 Team.
Mofenson LM; Lambert JS; Stiehm ER; Bethel J; Meyer WA; Whitehouse J; Moye J; Reichelderfer P; Harris DR; Fowler MG; Mathieson BJ; Nemo GJ
N Engl J Med; 1999 Aug; 341(6):385-93. PubMed ID: 10432323
[TBL] [Abstract][Full Text] [Related]
15. Potential risk factors for vertical HIV-1 transmission in Catalonia, Spain: the protective role of cesarean section. The Working Group on HIV-1 Vertical Transmission in Catalonia.
Maguire A; Sánchez E; Fortuny C; Casabona J
AIDS; 1997 Dec; 11(15):1851-7. PubMed ID: 9412704
[TBL] [Abstract][Full Text] [Related]
16. Therapeutic and other interventions to reduce the risk of mother-to-child transmission of HIV-1 in Europe. The European Collaborative Study.
Br J Obstet Gynaecol; 1998 Jul; 105(7):704-9. PubMed ID: 9692409
[TBL] [Abstract][Full Text] [Related]
17. Breastfeeding plus infant zidovudine prophylaxis for 6 months vs formula feeding plus infant zidovudine for 1 month to reduce mother-to-child HIV transmission in Botswana: a randomized trial: the Mashi Study.
Thior I; Lockman S; Smeaton LM; Shapiro RL; Wester C; Heymann SJ; Gilbert PB; Stevens L; Peter T; Kim S; van Widenfelt E; Moffat C; Ndase P; Arimi P; Kebaabetswe P; Mazonde P; Makhema J; McIntosh K; Novitsky V; Lee TH; Marlink R; Lagakos S; Essex M;
JAMA; 2006 Aug; 296(7):794-805. PubMed ID: 16905785
[TBL] [Abstract][Full Text] [Related]
18. Lamivudine-zidovudine combination for prevention of maternal-infant transmission of HIV-1.
Mandelbrot L; Landreau-Mascaro A; Rekacewicz C; Berrebi A; Bénifla JL; Burgard M; Lachassine E; Barret B; Chaix ML; Bongain A; Ciraru-Vigneron N; Crenn-Hébert C; Delfraissy JF; Rouzioux C; Mayaux MJ; Blanche S;
JAMA; 2001 Apr; 285(16):2083-93. PubMed ID: 11311097
[TBL] [Abstract][Full Text] [Related]
19. Efficacy of zidovudine and human immunodeficiency virus (HIV) hyperimmune immunoglobulin for reducing perinatal HIV transmission from HIV-infected women with advanced disease: results of Pediatric AIDS Clinical Trials Group protocol 185.
Stiehm ER; Lambert JS; Mofenson LM; Bethel J; Whitehouse J; Nugent R; Moye J; Glenn Fowler M; Mathieson BJ; Reichelderfer P; Nemo GJ; Korelitz J; Meyer WA; Sapan CV; Jimenez E; Gandia J; Scott G; O'Sullivan MJ; Kovacs A; Stek A; Shearer WT; Hammill H
J Infect Dis; 1999 Mar; 179(3):567-75. PubMed ID: 9952362
[TBL] [Abstract][Full Text] [Related]
20. [Estimate of HIV-1 infection prevalence in pregnant women and effectiveness of zidovudine administered during pregnancy in the prevention of vertical transmission].
Ramos Amador JT; Contreras JR; Bastero R; Barrio C; Moreno P; Delgado R; Muñoz E; Jiménez J
Med Clin (Barc); 2000 Mar; 114(8):286-91. PubMed ID: 10774515
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
